These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25858577)

  • 21. [Safety signal detection by the French Addictovigilance Network: Innovative methods of investigation, examples and usefulness for public health].
    Micallef J; Jouanjus É; Mallaret M; Lapeyre Mestre M
    Therapie; 2019 Dec; 74(6):579-590. PubMed ID: 31694770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Surveillance system on drug abuse: Interest of the French national OPPIDUM program of French addictovigilance network].
    Frauger E; Pochard L; Boucherie Q; Giocanti A; Chevallier C; Daveluy A; Gibaja V; Caous AS; Eiden C; Authier N; Le Boisselier R; Guerlais M; Jouanjus É; Lepelley M; Pizzoglio V; Pain S; Richard N; Micallef J;
    Therapie; 2017 Sep; 72(4):491-501. PubMed ID: 28343650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tramadol: new preparation. Capsules: central analgesic; step 2 on the WHO scale.
    Prescrire Int; 1998 Feb; 7(33):9-12. PubMed ID: 10183392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The tramadol option.
    Desmeules JA
    Eur J Pain; 2000; 4 Suppl A():15-21. PubMed ID: 11310478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of the abuse of tapentadol immediate release: the first 24 months.
    Dart RC; Cicero TJ; Surratt HL; Rosenblum A; Bartelson BB; Adams EH
    J Opioid Manag; 2012; 8(6):395-402. PubMed ID: 23264317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Slow-release oral morphine sulfate abuse: results of the postmarketing surveillance systems for psychoactive prescription drug abuse in France.
    Peyriere H; Eiden C; Micallef J; Lapeyre-Mestre M; Faillie JL; Blayac JP
    Eur Addict Res; 2013; 19(5):235-44. PubMed ID: 23428846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tramadol addiction.
    Patt S; McDiarmid T
    J Fam Pract; 2005 Apr; 54(4):356. PubMed ID: 15833228
    [No Abstract]   [Full Text] [Related]  

  • 28. [Psychotropic drug addiction: consumption study of specific population by the survey OPPIDUM 2004 from the CEIP network].
    Modelon H; Frauger E; Laurenceau D; Thirion X; Mallaret M; Micallef J;
    Therapie; 2007; 62(4):337-46. PubMed ID: 17983559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An update on zolpidem abuse and dependence.
    Victorri-Vigneau C; Gérardin M; Rousselet M; Guerlais M; Grall-Bronnec M; Jolliet P
    J Addict Dis; 2014; 33(1):15-23. PubMed ID: 24467433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medication misuse, abuse and dependence in chronic pain patients.
    Kouyanou K; Pither CE; Wessely S
    J Psychosom Res; 1997 Nov; 43(5):497-504. PubMed ID: 9394266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current trends in tramadol-related fatalities, Tehran, Iran 2005-2008.
    Iravani FS; Akhgari M; Jokar F; Bahmanabadi L
    Subst Use Misuse; 2010 Nov; 45(13):2162-71. PubMed ID: 20394504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug dependence and abuse potential of tramadol.
    Liu ZM; Zhou WH; Lian Z; Mu Y; Ren ZH; Cao JQ; Cai ZJ
    Zhongguo Yao Li Xue Bao; 1999 Jan; 20(1):52-4. PubMed ID: 10437125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medicines submitted to narcotics regulations in France, 1992-2007.
    Baumevieille M; Daveluy A; Maurain C; Bégaud B; Haramburu F
    Fundam Clin Pharmacol; 2009 Jun; 23(3):345-9. PubMed ID: 19453761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Which indicators can public health authorities use to monitor prescription drug abuse and evaluate the impact of regulatory measures? Controlling High Dosage Buprenorphine abuse.
    Pauly V; Frauger E; Pradel V; Rouby F; Berbis J; Natali F; Reggio P; Coudert H; Micallef J; Thirion X
    Drug Alcohol Depend; 2011 Jan; 113(1):29-36. PubMed ID: 20692778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification and tracking of Addictovigilance signals in general practice: which interactions between the general practitioners and the French Addictovigilance Network?
    Gentile G; Jego M; Spadari M; Griffiths K; Jouanjus E; Micallef J
    Fundam Clin Pharmacol; 2018 Dec; 32(6):643-651. PubMed ID: 30003596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tramadol-induced seizures and trauma.
    Farajidana H; Hassanian-Moghaddam H; Zamani N; Sanaei-Zadeh H
    Eur Rev Med Pharmacol Sci; 2012 Mar; 16 Suppl 1():34-7. PubMed ID: 22582482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimated magnitude of diversion and abuse of opioids relative to benzodiazepines in France.
    Pauly V; Pradel V; Pourcel L; Nordmann S; Frauger E; Lapeyre-Mestre M; Micallef J; Thirion X
    Drug Alcohol Depend; 2012 Nov; 126(1-2):13-20. PubMed ID: 22475815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Twenty-five years of the French Addictovigilance Network (FAN)].
    Micallef J; Mallaret M
    Therapie; 2016 Sep; 71(4):375-8. PubMed ID: 27296806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [OPPIDUM, a tool for assessing the local misuse of psychotropic drugs?].
    Bernard N; Bellemin B; Thirion X; Chuniaud-Louche C; Descotes J
    Therapie; 2002; 57(2):198-201. PubMed ID: 12185973
    [No Abstract]   [Full Text] [Related]  

  • 40. Basic pharmacology relevant to drug abuse assessment: tramadol as example.
    Raffa RB
    J Clin Pharm Ther; 2008 Apr; 33(2):101-8. PubMed ID: 18315774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.